About Me

Scott Oross is a partner in the Corporate practice of Paul Hastings and is based in the firm’s San Diego office.

Mr. Oross is a member of the Emerging Growth Company, Life Sciences and Mergers and Acquisitions practices. He represents companies in a number of different industries, with a primary focus on the life sciences industry, in a wide range of corporate transactions, including public and private offerings of equity and debt securities, mergers and acquisitions, and strategic collaborations. He also regularly advises boards of directors and management on a wide variety of strategic and corporate governance issues.

Experience

Recent Emerging Growth Company and Life Sciences Experience

  • Avalon Ventures in its $495 million life sciences collaboration with GlaxoSmithKline that has formed and funded 8 startup life sciences companies to date
  • Avalon Ventures in its participation in a $50 million Series A financing of Jnana Therapeutics, Inc.
  • Avalon Ventures in its participation in a $18 million Series A financing of Fortis Therapeutics, Inc.
  • Sydnexis, Inc. in its $35 million Series A financing
  • Acorns Grow Incorporated in its $70 million D financing
  • Avelas Biosciences, Inc. in its Series A, Series B and Series C financings totaling approximately $35 million
  • Enlibrium, Inc. in its $15 million Series A financing
  • Chef’d, Inc. in its $17.5 million Series A financing

Recent Mergers and Acquisitions Experience

  • GI Partners in its portfolio company’s $1.675 billion acquisition of ViaWest, Inc.
  • FairPoint Communications, Inc. in its $1.5 billion sale to Consolidated Communications, Inc.
  • Accelrys, Inc. in its $750 million sale via cash tender offer to Dassault Systèmes
  • Allbritton Communications Company in its $985 million sale of seven television stations and a cable/satellite news network to Sinclair Broadcast Group, Inc.
  • Barrington Broadcasting Group LLC in its $370 million sale of 18 television stations to Sinclair Broadcast Group, Inc.
  • LIN Media in its acquisition of 13 television stations from New Vision Television for $334.9 million
  • Zacharon Pharmaceuticals, Inc. in its combination with BioMarin Pharmaceutical Inc.
  • Valitas Health Services, Inc. in its $250 million acquisition of America Service Group Inc.

Speaking Engagements and Publications

  • Moderator, 2018 New York Venture Summit: Where's the Exit (2018)
  • Panelist, CONNECT Angel Investing Overview: Structuring the Deal (2017)
  • Panelist, Bio-Pharma Conference 2013: Innovations in China (2013)

Professional And Community Involvement

  • Board Member, CONNECT
  • Member, American Bar Association
  • Member, California State Bar Association

Education

  • Vanderbilt University School of Law, J.D. (John W. Wade Scholar), 2001
  • University of Notre Dame, B.A. (summa cum laude, Phi Beta Kappa), 1998